DoW, Ovarian Cancer, Pilot Award
About
Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. Distinctive Features: Innovation is key. Research projects that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the mechanism. Preliminary data are not required but are allowed for this mechanism. This mechanism includes a blinded pre-application component. Pre-applications to this funding opportunity will undergo a blinded pre-application screening. While preparing your pre-application, do not include any material that may identify the PI, a collaborator, or the organization of the PI or collaborator.
The DoW Ovarian Cancer Pilot Award is designed for researchers and scientific institutions pursuing groundbreaking work in ovarian cancer research. This grant specifically funds innovative research projects that challenge conventional thinking and introduce novel approaches to understanding and treating ovarian cancer. The program is ideal for researchers with exceptional scientific merit who are exploring cutting-edge concepts, theories, or methodologies that could catalyze significant breakthroughs in the field. Unlike many traditional research grants, preliminary data is not required to apply, making this an excellent opportunity for researchers with promising but early-stage innovative ideas. The pilot award mechanism emphasizes innovation as a core criterion—projects must demonstrate transformative potential rather than incremental advances. This grant supports the development of pilot studies that could ultimately lead to major discoveries and shift the trajectory of ovarian cancer research. Researchers nationwide are encouraged to submit bold, creative proposals that expand current understanding of ovarian cancer biology, treatment strategies, or patient outcomes. The blinded pre-application process ensures fair and objective evaluation of scientific merit without bias toward institutional prestige or researcher reputation.
Funding Facts
● Applications openDeadline
October 1, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Amount varies by cycle—consult official website
Deadline
2026-10-01
Grant Type
federal
Application Cycle
Annual with blinded pre-application screening
Best For
Researchers pursuing innovative ovarian cancer research with exceptional scientific merit
Frequently Asked Questions
Who is eligible for DoW, Ovarian Cancer, Pilot Award?
Specific eligibility criteria are not detailed in the available information. Typically, ovarian cancer research grants are available to researchers at academic institutions, medical centers, and research organizations. For complete and current eligibility requirements, including institutional qualifications and researcher credentials, please consult the official program website.
How much funding does DoW, Ovarian Cancer, Pilot Award provide?
The specific funding amount for this pilot award cycle is not specified in the available information. Funding amounts may vary by cycle. Please visit the official program website for current funding levels and financial details.
How do I apply for DoW, Ovarian Cancer, Pilot Award?
The application process includes a blinded pre-application component. When preparing your pre-application, ensure you do not include any identifying information about the principal investigator, collaborators, or their affiliated organizations, as the pre-application undergoes blinded screening. For detailed submission instructions, required documents, and deadlines, visit the official program website.
What can DoW, Ovarian Cancer, Pilot Award funding be used for?
This award supports innovative research projects that expand or modify current approaches to ovarian cancer. Funding is intended for research exploring novel concepts, theories, or methodologies in ovarian cancer that could lead to critical discoveries and major advancements. Projects must demonstrate exceptional innovation and scientific merit. Preliminary data is not required but may be included. Consult the official website for specific allowable use categories and restrictions.
Last updated: July 5, 2026